LeukoDx LP announces the appointment of Dr Bruce Davis, MD as Chief Scientific Officer of LeukoDx. The company is concurrently announcing the signing of a Memorandum of Understanding with Dr Davis’ company, Trillium Diagnostics, for in-licensing a patent and technology pertaining to quantifying CD64 at the point of care on LeukoDx’s compact flow cytometry platform.
Read MoreADA Recommends A1C as Diagnostic Test for Diabetes The American Diabetes Association‘s new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means o
Read MoreBio-Rad Laboratories Inc has announced that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
Read More
H1N1 Detection Set Granted FDA emergency use authorization The RealTime ready influenza A/H1N1 detection set, from Roche, Basel, Switzerland, has received emergency use authorization (EUA) from the FDA. The Roche kit detects RNA from the 2
Read MorePLUS Diagnostics announced that it has expanded its specialty anatomic pathology services with the launch of a national hematology/oncology offering.
Read More